|
CIVIL DOCKET |
UPDATED CIVIL DOCKET |
Summons Issued with Magistrate Consent Notice attached as to Bactolac Pharmaceutical Inc. on 1/24/2019; ScieGen Pharmaceuticals Inc. on 1/24/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (ceg) (Entered: 01/24/2019) |
COMPLAINT FOR PATENT INFRINGEMENT filed against Bactolac Pharmaceutical Inc., ScieGen Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. (Filing fee $ 400, receipt number 0311-2551039.) - filed by InterMune, Inc., Genentech, Inc. (Attachments: # 1 Exhibits 1-5, # 2 Civil Cover Sheet)(ceg) (Entered: 01/24/2019) |
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,383,150 B2; 8,420,674 B2; 7,767,225 B2; 7,988,994 B2; 8,753,679 B2. (Attachments: # 1 Order)(nms) (Entered: 08/21/2019) |
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg) (Entered: 01/24/2019) |
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/11/2018. Date of Expiration of Patent: see attached.Thirty Month Stay Deadline: 4/15/2022. (ceg) (Entered: 01/24/2019) |
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,383,150 B2; 8,420,674 B2; 7,767,225 B2; 7,988,994 B2; 8,753,679 B2. (ceg) (Entered: 01/24/2019) |
Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Roche Holdings, Inc. for Genentech, Inc.; Other Affiliate Genentech, Inc. for InterMune, Inc. filed by Genentech, Inc., InterMune, Inc. (ceg) (Entered: 01/24/2019) |
SUMMONS Returned Executed by InterMune, Inc., Genentech, Inc.. Bactolac Pharmaceutical Inc. served on 1/24/2019, answer due 2/14/2019. (Blumenfeld, Jack) (Entered: 01/24/2019) |
DECLARATION of Mailing, by Genentech, Inc., InterMune, Inc.. (Blumenfeld, Jack) Modified on 1/30/2019 (nms). (Entered: 01/25/2019) |
NOTICE of Appearance by R. Touhey Myer on behalf of Bactolac Pharmaceutical Inc., ScieGen Pharmaceuticals Inc. (Myer, R.) (Entered: 02/07/2019) |
Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Bactolac Pharmaceutical Inc. for ScieGen Pharmaceuticals Inc. filed by ScieGen Pharmaceuticals Inc.. (Myer, R.) (Entered: 02/07/2019) |
Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Bactolac Pharmaceutical Inc.. (Myer, R.) (Entered: 02/07/2019) |
STIPULATION TO EXTEND TIME for Defendants to answer the Complaint to March 15, 2019 - filed by Bactolac Pharmaceutical Inc., ScieGen Pharmaceuticals Inc.. (Myer, R.) (Entered: 02/07/2019) |
MOTION for Pro Hac Vice Appearance of Attorney Robert Silver and Salvatore Guerriero of Caesar Rivise, PC - filed by Bactolac Pharmaceutical Inc., ScieGen Pharmaceuticals Inc.. (Myer, R.) (Entered: 02/08/2019) |
MOTION for Pro Hac Vice Appearance of Attorney Mark E. Waddell, Warren K. MacRae and Ryan Hagglund of LOEB & LOEB LLP - filed by Genentech, Inc., InterMune, Inc.. (Jacobs, Karen) (Entered: 02/11/2019) |
STIPULATION of Dismissal without Prejudice, by Genentech, Inc., InterMune, Inc.. (Jacobs, Karen) Modified on 3/7/2019 (nms). (Entered: 03/06/2019) |
ANSWER to 1 Complaint, Affirmative Defenses, and COUNTERCLAIMS against All Plaintiffs, by ScieGen Pharmaceuticals Inc..(Myer, R.) Modified on 3/13/2019 (nms). (Entered: 03/12/2019) |
ANSWER to 15 Answer to Complaint, and Counterclaims, by Genentech, Inc., InterMune, Inc..(Jacobs, Karen) Modified on 4/2/2019 (nms). (Entered: 04/02/2019) |
NOTICE OF SUBSTITUTION OF COUNSEL re ScieGen Pharmaceuticals Inc.: Entry of appearance of attorney Patricia Smink Rogowski. Attorney R. Touhey Myer and Salvatore Guerriero terminated. (Rogowski, Patricia) (Entered: 07/23/2019) |
PROPOSED Consent Order of Dismissal, by ScieGen Pharmaceuticals Inc.. (Rogowski, Patricia) Modified on 8/20/2019 (nms). (Entered: 08/15/2019) |
SO ORDERED Granting 19 Proposed Consent Order of Dismissal (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 8/20/2019. (nms) (Entered: 08/20/2019) |